Pulmonology
Home Pulmonology
VA Slashes Use of Hydroxychloroquine to Treat COVID-19 Patients
Prescribing reduced to just three prescriptions in the last week as new research highlights possible dangers
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Burden of Severe COVID-19 High in California, Washington State
Length of stay was 9.3 days for survivors; probability high for ICU admission, mortality
Five-Day Course of Remdesivir Beneficial in Severe COVID-19
No significant difference seen in five-, 10-day course for severe COVID-19 without mechanical ventilation
Improving Glycemic Control May Also Aid COVID-19 Outcomes
Insulin infusion may reduce risk for severe disease in those with hyperglycemia and COVID-19
9.5 Percent Uninsured in U.S. From January Through June 2019
Overall, 13.7 percent of adults aged 18 to 64, 4.4 percent of children aged 0 to 17 were uninsured
Links Found Between Leaders of Medical Associations, Industry
Most leaders have ties to industry; considerable variation seen among 10 medical associations in U.S.
CV Toxicity Tied to Azithromycin and/or Hydroxychloroquine
Risk increased for prolonged QT and/or ventricular tachycardia, including torsades de pointes
CDC: Coronavirus Antibody Tests Still Not Accurate Enough
Too little is known about what the presence of antibodies means in terms of future immunity
Tooth Loss More Prevalent in Adults With Chronic Disease
Prevalence of edentulism, severe tooth loss ≥50 percent higher for adults with RA, asthma, diabetes
